DE69106407D1 - Verfahren zur Herstellung von rekombinantem menschlichem gamma-Interferon ohne Cystein und ohne Methionin am N-Terminal. - Google Patents

Verfahren zur Herstellung von rekombinantem menschlichem gamma-Interferon ohne Cystein und ohne Methionin am N-Terminal.

Info

Publication number
DE69106407D1
DE69106407D1 DE69106407T DE69106407T DE69106407D1 DE 69106407 D1 DE69106407 D1 DE 69106407D1 DE 69106407 T DE69106407 T DE 69106407T DE 69106407 T DE69106407 T DE 69106407T DE 69106407 D1 DE69106407 D1 DE 69106407D1
Authority
DE
Germany
Prior art keywords
methionine
cysteine
terminal
production
recombinant human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69106407T
Other languages
English (en)
Other versions
DE69106407T2 (de
Inventor
Ljuben Nikolaev Marekov
Rossiza Atanassova Vassileva
Vesselin Penkov Ivanov
Adriana Avram Sarafova
Rumen Georgiev Zanev
Ivan Georgiev Ivanov
Vessela Stefanova Ivanova
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmagen Ltd
Original Assignee
Pharmagen Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmagen Ltd filed Critical Pharmagen Ltd
Application granted granted Critical
Publication of DE69106407D1 publication Critical patent/DE69106407D1/de
Publication of DE69106407T2 publication Critical patent/DE69106407T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
DE1991606407 1990-01-24 1991-01-22 Verfahren zur Herstellung von rekombinantem menschlichem gamma-Interferon ohne Cystein und ohne Methionin am N-Terminal. Expired - Fee Related DE69106407T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BG9100690A BG52073B2 (en) 1990-01-24 1990-01-24 Method for the preparation of recombinant human noncystein -interferon, free of n-end methionine

Publications (2)

Publication Number Publication Date
DE69106407D1 true DE69106407D1 (de) 1995-02-16
DE69106407T2 DE69106407T2 (de) 1995-05-18

Family

ID=3922678

Family Applications (1)

Application Number Title Priority Date Filing Date
DE1991606407 Expired - Fee Related DE69106407T2 (de) 1990-01-24 1991-01-22 Verfahren zur Herstellung von rekombinantem menschlichem gamma-Interferon ohne Cystein und ohne Methionin am N-Terminal.

Country Status (6)

Country Link
EP (1) EP0446582B1 (de)
JP (1) JPH05176789A (de)
BG (1) BG52073B2 (de)
DE (1) DE69106407T2 (de)
ES (1) ES2066237T3 (de)
RU (1) RU2054044C1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2390292A1 (en) 1999-11-12 2001-05-25 Maxygen Holdings Ltd. Interferon gamma conjugates
CN1309423C (zh) 1999-11-12 2007-04-11 马克西根控股公司 干扰素γ偶联物
CA2417572A1 (en) * 2000-07-31 2003-01-28 Takeda Chemical Industries, Ltd. Process for producing recombined protein
CN1257186C (zh) * 2001-04-06 2006-05-24 马克西根控股公司 干扰素γ多肽变体
US6958388B2 (en) 2001-04-06 2005-10-25 Maxygen, Aps Interferon gamma polypeptide variants
US7038015B2 (en) 2001-04-06 2006-05-02 Maxygen Holdings, Ltd. Interferon gamma polypeptide variants
US7524931B2 (en) 2002-07-03 2009-04-28 Maxygen Holdings Ltd. Full-length interferon gamma polypeptide variants
BG66458B1 (bg) 2005-03-21 2014-10-31 Иван Иванов Средство за конкурентно инхибиране на ендогенен гама интерферон
US9359421B2 (en) 2008-04-08 2016-06-07 Tigo Gmbh Suppressor of the endogenous interferon-gamma
BG66517B1 (bg) 2008-04-08 2016-02-29 Tigo Gmbh Супресор на ендогенния човешки гама - интерферон
FR3052462A1 (fr) 2016-06-14 2017-12-15 Dna Script Variants d'une adn polymerase de la famille polx

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4855238A (en) * 1983-12-16 1989-08-08 Genentech, Inc. Recombinant gamma interferons having enhanced stability and methods therefor
EP0168008A3 (de) * 1984-07-10 1986-12-30 Takeda Chemical Industries, Ltd. Stabile Gamma-Interferonzusammensetzung
WO1986004067A1 (en) * 1984-12-27 1986-07-17 Suntory Limited Method for purifying an interferon
JPS61177996A (ja) * 1985-02-02 1986-08-09 Green Cross Corp:The インタ−フエロン−γの製造法
EP0315950A3 (de) * 1987-11-09 1990-05-23 Otsuka Pharmaceutical Co., Ltd. Verfahren zur Züchtung von Zellen, welche rekombinantes Protein exprimieren

Also Published As

Publication number Publication date
EP0446582A1 (de) 1991-09-18
DE69106407T2 (de) 1995-05-18
EP0446582B1 (de) 1995-01-04
ES2066237T3 (es) 1995-03-01
RU2054044C1 (ru) 1996-02-10
BG52073B2 (en) 1996-04-30
JPH05176789A (ja) 1993-07-20

Similar Documents

Publication Publication Date Title
ATE402957T1 (de) Analoge des menschlichen interferon-alpha mit niedriger toxizität
FI942017A (fi) Ihmisen interferonin stabilointi
DK203187A (da) Human g-csf proteinekspression
DE59101397D1 (de) O-glycosyliertes ifn-alpha.
DE69124258D1 (de) Tertiäre azeotrope zusammensetzungen von 43-10mee (cf 3?chfchfcf 2?cf 3?) und trans 1,2-dichloroethylen mit methanol oder ethanol
NL300116I1 (nl) Nieuwe osteoinductieve samenstellingen.
DE3586335D1 (de) Herstellung von gamma-interferon.
PT77573B (en) Human immune interferon protein and production thereof
IL72985A0 (en) Homogenous immune interferon fragment,its manufacture and pharmaceutical compositions containing it
DE69106407T2 (de) Verfahren zur Herstellung von rekombinantem menschlichem gamma-Interferon ohne Cystein und ohne Methionin am N-Terminal.
DE3789530D1 (de) Klonierung und Expression des sauren Fibroblastenwachstumsfaktors.
KR950702242A (ko) 사포린 함유 단백질의 재조합 생산방법(Recombinant production of saporin-containing proteins)
DE69734464D1 (de) Verfahren zur expression und herstellung von rekombinantem, menschlichem beta-cis-interferon
DE3485587D1 (de) Herstellung von aminocyclopropancarbonsaeuren und von peptiden.
DE69213362D1 (de) Elektrolyseur und Herstellung davon
DE3752184D1 (de) Herstellung und Verwendungen von gamma-Interferon
FI893587A0 (fi) Menetelmä ei-glykosyloidun rekombinantti-humaani-IL2:n valmistamiseksi sen pelkistyneessä muodossa
ES2142840T3 (es) Proteina que se une al interferon alfa/beta, su preparacion y las composiciones farmaceuticas que la contienen.
DE59404208D1 (de) Wässrige Edelmetallpräparate und deren Verwendung zur Herstellung von Edelmetalldekoren
EE9400337A (et) Alfainterferooni sisaldavad farmatseutilised kompositsioonid ja nende kasutusvõimalused
ATE45675T1 (de) Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen.
DK200089A (da) Expression af gamma-interferon i methylotrophe arter
ATA47989A (de) Verfahren zur industriellen herstellung von hochreinem menschlichem leukozyteninterferon
IT9021051A0 (it) "procedimento di estrzione e purificazione del gamma interferone umano ricombite"
ATE44045T1 (de) Menschliche gamma-interferon-polypeptid.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee